The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot clinical study of oral irinotecan HCl (VAL-413) in patients with recurrent pediatric solid tumors.
 
Jeffrey A. Bacha
Employment - Edison Oncology
Leadership - Edison Oncology; Rakovina Therapeutics; Sernova Corp.
Stock and Other Ownership Interests - Edison Oncology; Rakovina Therapeutics; Sernova Corp.
 
Dennis Brown
Employment - Edison Oncology; Kintara Therapeutics; Valent Technologies
Leadership - Edison Oncology; Rakovina Therapeutics
Stock and Other Ownership Interests - Edison Oncology; Kintara Therapeutics; Rakovina Therapeutics
 
James I. Geller
Consulting or Advisory Role - Fennec Pharma
 
Javier E. Oesterheld
Consulting or Advisory Role - Ymabs Therapeutics Inc
Speakers' Bureau - SERVIER
 
Meghann McManus
No Relationships to Disclose
 
Sarath Kanekal
Employment - Edison Oncology; Kintara Therapeutics
Stock and Other Ownership Interests - Edison Oncology; Kintara Therapeutics
 
Markos Leggas
No Relationships to Disclose
 
Lorena Lopez
Stock and Other Ownership Interests - Edison Oncology
Consulting or Advisory Role - Edison Oncology; Kintara Therapeutics
 
Neil Sankar
No Relationships to Disclose
 
Noymi Yam
Employment - Orbus Therapeutics
Stock and Other Ownership Interests - Edison Oncology; Orbus Therapeutics
Consulting or Advisory Role - Edison Oncology
 
Lars M. Wagner
No Relationships to Disclose